White label ELPA - ClinicalTrials.eu

Study on Adding Vasopressin to Treat Patients with Septic Shock

Recruiting

3 1 1
Investigated Diseases:
- Septic shock
Investigated Drugs:
- Argipressin
- Sodium Chloride
Study on Rituximab for Patients with Rheumatoid Arthritis: Comparing 200 mg and 1g Doses for Maintenance Treatment

Recruiting

3 1 1
Investigated Diseases:
- Rheumatoid arthritis
Investigated Drugs:
Long-term Safety and Efficacy Study of Etuvetidigene Autotemcel for Patients with Wiskott-Aldrich Syndrome

Recruiting

3 1 1
Investigated Diseases:
- Wiskott-Aldrich syndrome
Investigated Drugs:
- Etuvetidigene Autotemcel
Study on Melatonin and Quetiapine for Treating Insomnia in Adolescents with Psychiatric Disorders

Recruiting

4 1 1
Investigated Diseases:
Investigated Drugs:
- Quetiapine
- Melatonin
Study of ALE.P02 for Adults with Advanced or Metastatic Squamous Solid Tumors

Recruiting

2 1 1 1
Investigated Diseases:
- Neoplasm
Investigated Drugs:
- ALE.P02
- Pembrolizumab
Study on the Effects of Tirzepatide on Reducing Alcohol Intake in Patients with Schizophrenia and Alcohol Use Disorder

Recruiting

2 1 1
Investigated Diseases:
- Alcohol use disorder
- Schizophrenia
Investigated Drugs:
- Sodium Chloride
- Tirzepatide
Study on Nivolumab and MesoPher for Patients with Peritoneal Mesothelioma

Recruiting

2 1 1 1
Investigated Diseases:
- Peritoneal mesothelioma malignant
Investigated Drugs:
- AUTOLOGOUS DENDRITIC CELLS LOADED WITH ALLOGENIC ALLOGENEIC LYSATE OF MESOTHELIOMA CELL LINES
- Nivolumab
Comparison of bovine and marine chondroitin sulfate tablets (800 mg) in treating knee osteoarthritis pain and functional impairment

Recruiting

3 1 1 1
Investigated Diseases:
- Osteoarthritis
- Pain
Investigated Drugs:
- CHONDROITIN SULFATE SODIUM
Study on the Effects of TRI-001 for Patients with Chronic Limb Threatening Ischemia Due to Peripheral Arterial Disease

Recruiting

2 1
Investigated Diseases:
- Peripheral arterial occlusive disease
Investigated Drugs:
- ALLOGENEIC REGULATORY MACROPHAGES
Study on Ivosidenib for Patients with Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome with IDH1 Mutation After Stem Cell Transplant

Recruiting

2 1 1 1
Investigated Diseases:
Investigated Drugs:
- Ivosidenib

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies